Effect of nonpayment for preventable infections in U.S. hospitals.
about
Management of infections in critically ill patients.Quality of care delivered to hospitalized inflammatory bowel disease patientsDeclining incidence of candidemia and the shifting epidemiology of Candida resistance in two US metropolitan areas, 2008-2013: results from population-based surveillanceEffect of Medicare's nonpayment for Hospital-Acquired Conditions: lessons for future policy.State-Mandated Hospital Infection Reporting Is Not Associated With Decreased Pediatric Health Care-Associated InfectionsHAC-POA policy effects on hospitals, other payers, and patients.The evolving landscape of healthcare-associated infections: recent advances in prevention and a road map for research.A qualitative study of senior hospital managers' views on current and innovative strategies to improve hand hygiene.State-mandated reporting of health care-associated infections in the United States: trends over time.CMS reimbursement reform and the incidence of hospital-acquired pulmonary embolism or deep vein thrombosis.Physician organization care management capabilities associated with effective inpatient utilization management: a fuzzy set qualitative comparative analysis.The association of hospital prevention processes and patient risk factors with the risk of Clostridium difficile infection: a population-based cohort study.Differences in identifying healthcare associated infections using clinical vignettes and the influence of respondent characteristics: a cross-sectional survey of Australian infection prevention staff.Impact of laws aimed at healthcare-associated infection reduction: a qualitative study.Pediatric surgeon-directed wound classification improves accuracyQualitative study of views and experiences of performance management for healthcare-associated infections.Central line maintenance bundles and CLABSIs in ambulatory oncology patientsRemoving very low-performing therapists: A simulation of performance-based retention in psychotherapy.Temporal trends of ventilator-associated pneumonia incidence and the effect of implementing health-care bundles in a suburban communityPhysician Motivation: Listening to What Pay-for-Performance Programs and Quality Improvement Collaboratives Are Telling Us.Beyond Measurement and Reward: Methods of Motivating Quality Improvement and Accountability.Quality and innovations for caring hospitalized older persons in the unites StatesFalse Dichotomies and Health Policy Research Designs: Randomized Trials Are Not Always the Answer.Medicare non-payment of hospital-acquired infections: infection rates three years post implementation.Electronic medical records and quality of cancer care.Impact of Medicare's payment policy on mediastinitis following coronary artery bypass graft surgery in US hospitals.Proton pump inhibitors and histamine-2 receptor antagonists in the intensive care setting: focus on therapeutic and adverse events.Influence of state laws mandating reporting of healthcare-associated infections: the case of central line-associated bloodstream infections.Infection Prevention in the Hospital from Past to Present: Evolving Roles and Shifting Priorities.Hospital-Acquired Conditions Are Associated with Worse Outcomes in Crohn's Disease-Related Hospitalizations.Implantable Device-Related Infection.Research Methods in Healthcare Epidemiology and Antimicrobial Stewardship: Use of Administrative and Surveillance Databases.Financial Incentives to Encourage Value-Based Health Care.The Relationship Between Parenteral Nutrition and Central Line-Associated Bloodstream Infections.Impact of State Reporting Laws on Central Line-Associated Bloodstream Infection Rates in U.S. Adult Intensive Care Units.Trends in mortality, length of stay, and hospital charges associated with health care-associated infections, 2006-2012.A multifaceted quality improvement strategy reduces the risk of catheter-associated urinary tract infection.Near-perfect compliance with SCIP Inf-9 had no effect on catheter utilization or urinary tract infections at an academic medical center.Reducing excess readmissions: promising effect of hospital readmissions reduction program in US hospitals.Factors and Costs Associated With Delay in Treatment Initiation and Prolonged Length of Stay With Inpatient EPOCH Chemotherapy in Patients With Hematologic Malignancies.
P2860
Q26828775-D52337E2-77A4-41C5-92B6-7A928CCD0AA1Q26828910-AE621719-1151-4DF3-AAE5-BDB7E00E0D9AQ28545137-FDC69686-0641-4C02-B968-3378561E6DE2Q33901732-E26BECD9-C546-4877-8582-A749C835DA14Q34255748-96B55299-F237-4EC9-832B-241B9E0F4EF8Q34380473-EA89E0F8-205A-4C9C-B8CD-E09199E01B54Q34482229-974C18CF-57E2-4F93-BFF2-144329F58707Q34544031-100DE7DE-D459-46BA-AB85-305ACE5E8AB8Q34747342-5FFC8B4F-38D6-4B90-80F4-CCCCCE9ADE24Q35396809-6AC5162D-D28E-4DAD-8912-5D63A11E3323Q35482542-50352F7F-DBA4-484D-B37D-E4349C81CD63Q35793012-F5A3B2C6-42B3-4CEC-9035-2F43048D188AQ35863754-A59C7766-54DE-4827-A603-29A4A206F09AQ36075239-406B5FF0-6E06-4CF1-AF10-0D0482FDE72CQ36745905-9CB2DDCE-524D-4510-9657-A559C788B8ADQ37193759-B3197397-E697-464E-95AF-B169DCA76365Q37268808-DFFD5680-5C18-4922-B047-2EC9D76F6716Q37274798-D7E498CE-2E52-425F-A1D4-8BE38DAD9D18Q37280899-C3E6D73B-9B95-4687-89D5-D8C2318CDF5FQ37399546-5A968A46-D12F-4628-8A14-B1F112F943F4Q37422043-67F31DC5-5BDC-4CDE-9C04-D9C3FC355FA1Q37514006-06E18B36-0E45-4B69-9227-F5D82BE45365Q37605231-AB8D169D-5AD2-433D-A26E-57259116B1ACQ37698051-942C7C27-ECA8-4DB8-9E68-11B30944DDC1Q38149814-4132A98B-656A-4AC0-939A-394F9D101E4CQ38179951-362CE0DD-D173-4C26-8BA6-FD47E49C15C3Q38271282-980448B2-F66C-4BCB-B610-79A5D5FF066FQ38448697-3B27F80A-DFA9-4A9E-8CFB-6773627C4B5AQ38815490-D621218A-1E19-4196-8968-E6972D92CAA6Q38841192-6FF564F0-D214-4A06-8151-D317723717EBQ38907537-7C8475BC-D60C-488E-BF26-1CCD627CFDCBQ38940002-A569F361-89C2-4DAD-AF65-7D1C8883C7FAQ38999168-E6FF6117-0A68-4F03-BBBB-F5BA748827C7Q39029070-249C787E-2025-45F6-9CF0-40AEAE057239Q39566037-642A64AE-B80B-4453-BEC1-CDA61816A034Q39748531-6451999B-2D63-4135-AA79-729787634003Q40164988-C46F44CC-EF82-4229-AE7F-DDE01DC05D13Q40255417-03E357A6-208A-4A36-82CD-2F06A52DDFFBQ40316340-9483913C-3640-4FE2-B7DB-825A498300F9Q40348207-AC18A0E4-7191-4BFA-BE49-AB9134ED6252
P2860
Effect of nonpayment for preventable infections in U.S. hospitals.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Effect of nonpayment for preventable infections in U.S. hospitals.
@en
Effect of nonpayment for preventable infections in U.S. hospitals.
@nl
type
label
Effect of nonpayment for preventable infections in U.S. hospitals.
@en
Effect of nonpayment for preventable infections in U.S. hospitals.
@nl
prefLabel
Effect of nonpayment for preventable infections in U.S. hospitals.
@en
Effect of nonpayment for preventable infections in U.S. hospitals.
@nl
P2093
P356
P1476
Effect of nonpayment for preventable infections in U.S. hospitals
@en
P2093
Alison Tse
Ashish K Jha
Charlene Gay
David Cole
Donald A Goldmann
Grace M Lee
John Jernigan
Richard Platt
Scott K Fridkin
Stephen B Soumerai
P304
P356
10.1056/NEJMSA1202419
P407
P577
2012-10-01T00:00:00Z